Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse
Hemophilia A, a bleeding disorder resulting from F8 mutations, can only be cured by gene therapy. A promising strategy is CRISPR-Cas9-mediated precise insertion of F8 in hepatocytes at highly expressed gene loci, such as albumin (Alb). Unfortunately, the precise in vivo integration efficiency of a l...
Sábháilte in:
Príomhchruthaitheoirí: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formáid: | Artigo |
Teanga: | Béarla |
Foilsithe / Cruthaithe: |
2019
|
Rochtain ar líne: | https://doi.org/10.1186/s13059-019-1907-9 https://genomebiology.biomedcentral.com/track/pdf/10.1186/s13059-019-1907-9 |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|